(S)-VANOL膦酸酯, (6aS)-14-Hydroxy-6,7-diphenyl-14-oxide-dinaphtho[1,2-d:2',1'-f][1,3,2]dioxaphosphepin

(8aR)-18-Hydroxy-8,9-diphenyl-18-oxide-diphenanthro[4,3-d:3',4'-f][1,3,2]dioxaphosphepin

(R)-VAPOL膦酸酯

(3aS,8aS)-4,4,8,8-四(3,5-二叔丁基苯基)-6-羟基-2,2-二对甲苯基四氢-6-氧化物-[1,3]二氧并[4,5-e][1,3,2]二氧磷, (3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-p-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine

(3aR,8aR)-4,4,8,8-四(3,5-二叔丁基苯基)-6-羟基-2,2-二对甲苯基四氢-6-氧化物-[1,3]二氧并[4,5-e][1,3,2]二氧磷, (3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-p-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine

(3aR,8aR)-四氢-6-羟基-2,2-二甲基-4,4,8,8-四(4-(叔丁基)苯基)-6-氧化物-[1,3]二氧并[4,5-e][1,3,2]二氧磷, (3aR,8aR)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetrakis(4-(tert-butyl)phenyl)-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine

(11aR)-3,7-Bis [3,5-双(叔丁基)-4-甲氧基苯基] -10,11,12,13-四氢-10,10,13,13-四甲基-5-羟基[ 7,1-de:1',7'-fg] [1,3,2]二氧杂磷霉素, (11aR)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

(11aR)-3,7-双(4-氯苯基)-10,11,12,13-四氢-10,10,13,13-四甲基-5-羟基-二茚基[7,1-de:1', (11aR)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

Tris(trans-1,2-bis(4-(trifluoromethyl)phenyl)ethene)nickel(0)

CALLERY? Sodium hexamethyldisilazane

CALLERY? Tri-n-butylborane-3-methoxypropylamine